BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37108151)

  • 1. Rapid and Robust Multi-Phenotypic Assay System for ALS Using Human iPS Cells with Mutations in Causative Genes.
    Kondo T; Ebinuma I; Tanaka H; Nishikawa Y; Komiya T; Ishikawa M; Okano H
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons.
    Wainger BJ; Kiskinis E; Mellin C; Wiskow O; Han SS; Sandoe J; Perez NP; Williams LA; Lee S; Boulting G; Berry JD; Brown RH; Cudkowicz ME; Bean BP; Eggan K; Woolf CJ
    Cell Rep; 2014 Apr; 7(1):1-11. PubMed ID: 24703839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis.
    Imamura K; Izumi Y; Watanabe A; Tsukita K; Woltjen K; Yamamoto T; Hotta A; Kondo T; Kitaoka S; Ohta A; Tanaka A; Watanabe D; Morita M; Takuma H; Tamaoka A; Kunath T; Wray S; Furuya H; Era T; Makioka K; Okamoto K; Fujisawa T; Nishitoh H; Homma K; Ichijo H; Julien JP; Obata N; Hosokawa M; Akiyama H; Kaneko S; Ayaki T; Ito H; Kaji R; Takahashi R; Yamanaka S; Inoue H
    Sci Transl Med; 2017 May; 9(391):. PubMed ID: 28539470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing effects of microgravity and amyotrophic lateral sclerosis in the mouse ventral lumbar spinal cord.
    Yoshikawa M; Ishikawa C; Li H; Kudo T; Shiba D; Shirakawa M; Muratani M; Takahashi S; Aizawa S; Shiga T
    Mol Cell Neurosci; 2022 Jul; 121():103745. PubMed ID: 35660087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling amyotrophic lateral sclerosis in pure human iPSc-derived motor neurons isolated by a novel FACS double selection technique.
    Toli D; Buttigieg D; Blanchard S; Lemonnier T; Lamotte d'Incamps B; Bellouze S; Baillat G; Bohl D; Haase G
    Neurobiol Dis; 2015 Oct; 82():269-280. PubMed ID: 26107889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
    Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.
    Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M
    Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
    Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
    Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell transcriptomics identifies master regulators of neurodegeneration in SOD1 ALS iPSC-derived motor neurons.
    Namboori SC; Thomas P; Ames R; Hawkins S; Garrett LO; Willis CRG; Rosa A; Stanton LW; Bhinge A
    Stem Cell Reports; 2021 Dec; 16(12):3020-3035. PubMed ID: 34767750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
    Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
    Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SQSTM1, a protective factor of SOD1-linked motor neuron disease, regulates the accumulation and distribution of ubiquitinated protein aggregates in neuron.
    Mitsui S; Otomo A; Sato K; Ishiyama M; Shimakura K; Okada-Yamaguchi C; Warabi E; Yanagawa T; Aoki M; Shang HF; Hadano S
    Neurochem Int; 2022 Sep; 158():105364. PubMed ID: 35640762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
    Hadano S; Mitsui S; Pan L; Otomo A; Kubo M; Sato K; Ono S; Onodera W; Abe K; Chen X; Koike M; Uchiyama Y; Aoki M; Warabi E; Yamamoto M; Ishii T; Yanagawa T; Shang HF; Yoshii F
    Hum Mol Genet; 2016 Aug; 25(15):3321-3340. PubMed ID: 27439389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
    Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
    PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations.
    Kim BW; Jeong YE; Wong M; Martin LJ
    Acta Neuropathol Commun; 2020 Jan; 8(1):7. PubMed ID: 32005289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor neurons from ALS patients with mutations in C9ORF72 and SOD1 exhibit distinct transcriptional landscapes.
    Wong CO; Venkatachalam K
    Hum Mol Genet; 2019 Aug; 28(16):2799-2810. PubMed ID: 31107959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.
    Wang L; Yi F; Fu L; Yang J; Wang S; Wang Z; Suzuki K; Sun L; Xu X; Yu Y; Qiao J; Belmonte JCI; Yang Z; Yuan Y; Qu J; Liu GH
    Protein Cell; 2017 May; 8(5):365-378. PubMed ID: 28401346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor Neuron Generation from iPSCs from Identical Twins Discordant for Amyotrophic Lateral Sclerosis.
    Seminary ER; Santarriaga S; Wheeler L; Mejaki M; Abrudan J; Demos W; Zimmermann MT; Urrutia RA; Fee D; Barkhaus PE; Ebert AD
    Cells; 2020 Feb; 9(3):. PubMed ID: 32121108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons.
    Chen H; Qian K; Du Z; Cao J; Petersen A; Liu H; Blackbourn LW; Huang CL; Errigo A; Yin Y; Lu J; Ayala M; Zhang SC
    Cell Stem Cell; 2014 Jun; 14(6):796-809. PubMed ID: 24704493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstream Effects of Mutations in
    Dash BP; Freischmidt A; Weishaupt JH; Hermann A
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.